Living with PTSD can make ordinary decisions feel unusually heavy. Even making a phone call about treatment may bring up doubt, vigilance, or the familiar concern that you have already tried too much without finding enough relief.
At our Milwaukee clinic, we believe a consultation should create room for clear questions. It should not pressure you toward a decision before you understand the treatment, the limits of the evidence, and what care may look like afterward. If you are considering a stellate ganglion block for PTSD in Milwaukee, WI, bringing a thoughtful set of questions can help you feel more grounded in the conversation.
SGB is not right for every person with PTSD. It is an off-label clinical use, meaning it is not FDA-approved specifically for PTSD. Still, it has become an area of meaningful clinical interest, particularly for people whose nervous systems remain caught in a persistent state of alarm.
This article is for educational purposes only. It does not replace individualized medical advice or emergency care. Treatment eligibility, potential benefits, and risks must be assessed by a qualified clinician who understands your health history.
SGB is, and what it is not
A stellate ganglion block, often called an SGB, is an injection performed near the stellate ganglion, a group of nerves in the neck that is involved in the sympathetic nervous system. This is the system associated with the body’s fight, flight, or freeze response.
For someone with PTSD, that response may not feel like a momentary reaction. It can feel like the background condition of daily life. Sleep may remain light. Sounds may land too sharply. A neutral interaction can register as danger before you have time to think.
Research has explored whether SGB may reduce PTSD symptom severity for some patients. In one randomized clinical trial, participants who received paired SGB treatments showed a greater reduction in PTSD symptoms than those who received sham treatment, although the study population and treatment setting matter when considering what those findings may mean for an individual person. A randomized trial of SGB and PTSD symptoms offers an important part of that conversation (Rae Olmsted et al., 2020).
The procedure is not psychotherapy. It does not erase what happened to you, rewrite memory, or replace the relationships and supports that may help you heal. We see it as a medical intervention that may be worth discussing within the larger context of your mental health care.
A useful first question is simple:
What symptoms are you hoping this treatment may help address?
Be as specific as you can. Hypervigilance, exaggerated startle, disrupted sleep, irritability, panic, and the feeling of never being fully safe may each shape the consultation differently.
Ask whether your history makes SGB appropriate
PTSD is not one experience. Trauma can be acute or cumulative. Symptoms can coexist with depression, anxiety, chronic pain, substance use concerns, or difficult medication histories. A meaningful consultation should make space for the whole picture.
We encourage you to ask:
What parts of my psychiatric and medical history matter most here?
How will you review my current medications and prior treatments?
Are there health conditions that could make this procedure less appropriate or require additional planning?
Do my current symptoms suggest that another level of support is needed first?
This is particularly important if PTSD has left you feeling unsafe, disconnected, or overwhelmed by thoughts of harming yourself. An SGB consultation is not a substitute for urgent crisis care. If you are in immediate danger, call 911 or go to the nearest emergency department. You can also call or text the 988 Suicide and Crisis Lifeline at any time.
We also want to understand what has already been part of your care. PTSD treatment may involve therapy, medication, changes in daily structure, support from trusted people, and other interventions. Current evidence-based PTSD care discussions continue to emphasize that treatment planning should be individualized rather than reduced to a single technique (Bajor et al., 2022).
If depression has also been part of your history, it may be helpful to review your depression treatment options separately with a clinician. The same is true if you have been navigating treatment-resistant depression, bipolar symptoms, or changes in substance use. Each part of your health deserves direct attention rather than assumptions.
Understand the evidence without asking it to promise too much
It is reasonable to want a direct answer: Will this work for me?
No careful clinician can answer that with certainty. The existing research on SGB for PTSD is promising enough to warrant serious discussion, but it remains an evolving clinical area. Reviews of the literature have identified variation in study design, patient populations, follow-up periods, and treatment protocols. A systematic review of psychiatric SGB research describes both the interest in this approach and the need for continued high-quality research (Kerzner et al., 2021).
Ask questions that make room for honesty:
What does the research suggest, and what does it not establish?
How do you define a meaningful response to treatment?
How long might a change in symptoms last, if I experience one?
What would we do if I do not notice the change I hoped for?
Would you recommend continuing with my therapist, psychiatrist, or other providers?
There is value in asking not only about improvement, but also about uncertainty. We would rather have a candid conversation about the limits of a treatment than have you arrive with expectations no medical procedure can responsibly meet.
Ask exactly how the procedure is performed
The details matter. Knowing what will happen can make the day feel less mysterious, especially when PTSD has made medical environments, unfamiliar sensations, or loss of control difficult.
At your consultation, ask:
Who will perform my SGB, and what is their experience with this procedure?
Will imaging guidance be used during the injection?
What should I expect before, during, and immediately after treatment?
How long should I plan to be at the clinic?
Will I need someone to drive me home?
SGB has been used in medicine for decades, including for pain-related conditions, but every procedure has potential risks. The precise risk discussion should be personal to your health history and the technique being considered. Clinical reviews of SGB as an adjunctive treatment discuss the procedure’s broader uses and the importance of careful patient selection and technique (Kirkpatrick et al., 2023).
You should feel comfortable asking about temporary effects as well as uncommon but more serious complications. For example, some people may experience short-lived changes such as eyelid drooping, a red eye, nasal congestion, hoarseness, or a change in the sensation of swallowing after an SGB. These effects can be unsettling if they are unexpected. They should be explained before treatment, not after.
Talk through safety, logistics, and the days after treatment
A procedure does not end when you leave the treatment room. For many patients, the practical questions are the ones that determine whether care is manageable.
Ask about:
Whether I need to fast or change any medications before the procedure
How I should arrange transportation and time away from work or caregiving
Who I should contact if I have questions after I go home
What symptoms would require an urgent call or emergency evaluation
When follow-up will happen and how we will discuss my response
We encourage patients to bring a current medication list, relevant medical records when available, and notes about their PTSD symptoms. You do not need to tell your entire story perfectly in one appointment. A few concrete examples of what life has been like lately can be enough to begin.
It can also help to bring someone you trust, if that feels supportive. PTSD often makes it difficult to hold onto information while you are in a new clinical setting. Another person can listen, take notes, or simply be nearby. Building a reliable support system can matter before, during, and after any significant care decision.
Make follow-up part of the decision, not an afterthought
We do not view an SGB as a standalone event disconnected from the rest of your care. We want to know who is supporting you, what treatments you have tried, and how you would like us to communicate with your existing providers.
Ask us how we approach follow-up. Ask how we monitor changes in sleep, startle response, emotional regulation, anxiety, and your ability to participate in the parts of life that matter to you. A review of non-pain SGB indications notes the growing interest in these applications while underscoring the need for thoughtful clinical evaluation (Feigin et al., 2023).
For some people, a reduction in constant physiological alarm may create more room to engage in therapy or reconnect with daily routines. That possibility is not a guarantee. It is, however, one reason we believe follow-up deserves as much attention as the procedure itself.
We also offer ketamine treatment and SPRAVATO® services, and we can discuss whether another service line should be considered separately based on your diagnosis, history, current medications, and treatment goals. Ketamine for psychiatric uses is off-label, while SPRAVATO® is prescribed only when clinically appropriate.
If you are considering SGB for PTSD, we invite you to contact Edelica Health at 414-441-5707 to schedule a consultation. We will take the time to discuss your history, your questions, and whether this off-label treatment belongs in your care plan.
Works Cited
1. Rae Olmsted KL, et al. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/31693083/
2. Bajor LA, et al. An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD), 2022 update. https://pubmed.ncbi.nlm.nih.gov/36162349/
3. Kerzner J, et al. Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape. https://pubmed.ncbi.nlm.nih.gov/34901677/
4. Kirkpatrick K, et al. A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality. https://pubmed.ncbi.nlm.nih.gov/36949968/
5. Feigin G, et al. Stellate ganglion block for non-pain indications: a scoping review. https://pubmed.ncbi.nlm.nih.gov/36727500/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.